Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Transcriptomic and epigenetic analysis of adipose tissue in Cushing Syndrome [human]

ABSTRACT: Transcriptomic and epigenetic analysis of adipose tissue in Cushing Syndrome [human]

PROVIDER: PRJNA588382 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR12186952_1.fastq.gz	Fastqsanger.gz
	SRR12186952_2.fastq.gz	Fastqsanger.gz
	SRR12186953_1.fastq.gz	Fastqsanger.gz
	SRR12186953_2.fastq.gz	Fastqsanger.gz
	SRR12186954_1.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 62

Similar Datasets

Transcriptomic and epigenetic analysis of adipose tissue in Cushing Syndrome [mouse]

Project description:Chronic glucocorticoids (GCs) exposure, resulting from endogenous Cushing Syndrome (CS) or prescribed GCs therapy, is associated with a high cardiometabolic burden. Moreover, previous studies have reported persistence of metabolic syndrome features after remission of hypercortisolism and in particular in visceral adipose tissue (VAT). Thus, in this study we want to analyze the transcriptomic alterations in VAT during active and cured CS and correlate these persistent gene expression changes with histone modifications induced by GCs.

2021-09-03 | GSE153934 | GEO

Transcriptomic and epigenetic analysis of adipose tissue in Cushing Syndrome [human]

2021-09-03 | GSE140126 | GEO

Transcriptomic and epigenetic analysis of adipose tissue in Cushing Syndrome [mouse]

Project description:Transcriptomic and epigenetic analysis of adipose tissue in Cushing Syndrome [mouse]

| PRJNA644580 | ENA

RNA Seq off visceral adipose tissue from human Cushing patients and Controls

Project description:Visceral adipose tissue from human patients with Cushing was sequnced to identify novel markers of disease progression and other changes related to the disease in adipose tissue.

2023-08-30 | GSE218965 | GEO

Implication of Acyl Coenzyme A Binding Protein (ACBP) in Cushing Syndrome

Project description:Acyl coenzyme A binding protein (ACBP), encoded by the diazepam binding protein (DBI) gene, plays a pivotal role in stimulating appetite and lipo-anabolic reactions, showing correlations with laboratory indications of metabolic syndrome in ostensibly healthy individuals. In a screening effort targeting inhibitors of ACBP/DBI expression among distinct neuroendocrine factors, we discovered that glucocorticoids induce ACBP/DBI secretion in cultured cells. In mouse models of iatrogenic Cushing syndrome, antibody-mediated neutralization of ACBP/DBI prevented the metabolic consequences of prolonged glucocorticoid administration. Our findings suggest that a surge in extracellular ACBP/DBI may mediate crucial aspects of Cushing syndrome.

2024-10-02 | GSE248672 | GEO

RNA Seq off visceral adipose tissue from human Cushing patients and Controls

Project description:RNA Seq off visceral adipose tissue from human Cushing patients and Controls

| PRJNA906468 | ENA

Implication of Acyl Coenzyme A Binding Protein (ACBP) in Cushing Syndrome

Project description:Implication of Acyl Coenzyme A Binding Protein (ACBP) in Cushing Syndrome

| PRJNA1045563 | ENA

Gene methylation profiles in visceral adipose tissue of obese men with and without the metabolic syndrome

Project description:Evaluate differences in gene methylation levels between obese men with and without the metabolic syndrome Visceral adipose tissue from obese men with the metabolic syndrome (MetS+, N=7) vs. obese men without the metabolic syndrome (MetS-, N=7)

2014-02-07 | E-GEOD-54776 | biostudies-arrayexpress

DNA methylation analysis of subcutaneous adipose tissue abdominal versus subcutenaous adipose tissue gluteal

Project description:In humans, adipose tissue is distributed in subcutaneous abdominal and subcutaneous gluteal depots that comprise a variety of functional differences. Whereas energy storage in gluteal adipose tissue has been shown to mediate a protective effect, an increase of abdominal adipose tissue is associated with metabolic disorders. However, the molecular basis of depot-specific characteristics is not completely understood yet. Using array-based analyses of transcription profiles, we identified a specific set of genes that was differentially expressed between subcutaneous abdominal and gluteal adipose tissue. To investigate the role of epigenetic regulation in depot-specific gene expression, we additionally analyzed genome-wide DNA methylation patterns in abdominal and gluteal depots. By combining both data sets, we identified a highly significant set of depot-specifically expressed genes that appear to be epigenetically regulated. Interestingly, the majority of these genes form part of the homeobox gene family. Moreover, genes involved in fatty acid metabolism were also differentially expressed. Therefore we suppose that changes in gene expression profiles might account for depot-specific differences in lipid composition. Indeed, triglycerides and fatty acids of abdominal adipose tissue were more saturated compared to triglycerides and fatty acids in gluteal adipose tissue. Taken together, our results uncover clear differences between abdominal and gluteal adipose tissue on the gene expression and DNA methylation level as well as in fatty acid composition. Therefore, a detailed molecular characterization of adipose tissue depots will be essential to develop new treatment strategies for metabolic syndrome associated complications. DNA methylation profiles of abdominal adipose tissue (6 samples) and gluteal adipose tissue (6 samples) were generated using Infinium methylation 450K BeadChips from Illumina (Illumina, San Diego, USA).

2013-11-15 | E-GEOD-47512 | biostudies-arrayexpress

Reversing gut microbiome-driven adipose tissue inflammation alleviates metabolic syndrome.

Project description:Reversing gut microbiome-driven adipose tissue inflammation alleviates metabolic syndrome.

| PRJNA907777 | ENA